Evidence map›Paper›PMID 28515318›Full record

ArticleThe Journal of biological chemistry2017

Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas.

Braden D Siempelkamp, Manoj K Rathinaswamy, Meredith L Jenkins, John E Burke

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Subcellular Cartography of the Phosphoinositide Multiverse.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2026
    Review
  5. Article
  6. Article
  7. Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Structural basis of phosphatidylinositol 3-kinase C2α function.Nature structural & molecular biology · 2022
    Article
  18. Article
  19. PI3K and AKT at the Interface of Signaling and Metabolism.Current topics in microbiology and immunology · 2022
    Article
  20. The orchestrated signaling by PI3Kα and PTEN at the membrane interface.Computational and structural biotechnology journal · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Braden D SiempelkampDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8W 2Y2, Canada.
Manoj K RathinaswamyDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8W 2Y2, Canada.
Meredith L JenkinsDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8W 2Y2, Canada.
John E BurkeDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8W 2Y2, Canada. Electronic address: jeburke@uvic.ca.
University of Victoria · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Class IA PI3Ks are involved in the generation of the key lipid signaling molecule phosphatidylinositol 3,4,5-trisphosphate (PIP

Indexed as

Models, MolecularSecond Messenger SystemsAmino Acid SubstitutionAnimalsClass I Phosphatidylinositol 3-KinasesDeuterium Exchange MeasurementEnzyme ActivationHumansLipid BilayersLiposomesMutagenesis, Site-DirectedPeptide FragmentsPhosphatidylinositol 3-KinasesPhosphatidylinositol PhosphatesPoint MutationProtein ConformationClass I Phosphatidylinositol 3-KinasesHRAS protein, humanLipid BilayersLiposomesPeptide Fragmentsphosphatidylinositol 3,4,5-triphosphatePhosphatidylinositol 3-KinasesPhosphatidylinositol PhosphatesPIK3CA protein, humanPIK3CD protein, humanProto-Oncogene Proteins p21(ras)Recombinant Proteinshydrogen exchange mass spectrometrylipid–protein interactionlipid signalingphosphatidylinositide 3-kinase (PI 3-kinase)phosphoinositideRas protein

Identifiers

PMID28515318
PMCPMC5519374
OpenAlexW2615972939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.